Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Short Interest Update

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 26 shares, an increase of 550.0% from the August 15th total of 4 shares. Based on an average daily volume of 743 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Ambu A/S Price Performance

AMBBY stock opened at $11.00 on Friday. The firm has a 50 day simple moving average of $10.70 and a two-hundred day simple moving average of $10.52. The stock has a market cap of $2.58 billion, a PE ratio of 36.67 and a beta of 0.93. Ambu A/S has a one year low of $8.54 and a one year high of $16.78. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.92 and a quick ratio of 1.73.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings data on Tuesday, August 25th. The company reported $0.09 earnings per share for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.56%. The firm had revenue of $255.12 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring.

Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics.